Friday 22nd March 2019
Dr. Elizabeth Renzoni has been working as a consultant respiratory physician at Royal Brompton Hospital in the ILD Unit and an honorary senior lecturer at Imperial College London since 2006. We spoke to her about her career in research.
Wednesday 20th March 2019
Iloprost is used to treat a range of conditions, such as scleroderma, Raynaud's phenomenon, pulmonary hypertension and other diseases where blood vessels are constricted. By relaxing the blood vessels, it makes it easier for blood to flow through, helping to limit the symptoms.
Thursday 14th March 2019
SRUK recently funded David and his team to investigate factors that contribute to the development of calcinosis in scleroderma patients. Find out more about him in our new Meet the Scientist series.
Tuesday 12th March 2019
Here is a little insight into the lives of some of the researchers we fund, what keeps them in the laboratory and the future of research.
Friday 8th March 2019
Here’s Sylvia Herring’s story of how she used diet and exercise to help cope with her recent diagnosis of systemic scleroderma.
Thursday 28th February 2019
Vitamin D deficiency has been linked to several autoimmune diseases, such as rheumatoid arthritis, lupus and multiple sclerosis, and is seen almost universally in patients with systemic sclerosis (SSc). This has garnered significant attention, alongside recent data suggesting that vitamin D plays a role in the functioning of the immune system.
Tuesday 26th February 2019
The results of a study spanning several years indicate that there may be long-term benefits of stem cell transplant in those suffering from severe scleroderma. This multi-centre study by researchers at Dartmouth, alongside other institutions, and led by Dr Jennifer Franks focused on comparing improvements in those treated with cyclophosphamide, the more conventional drug therapy for scleroderma, to those who had undergone a stem cell transplant.
Thursday 21st February 2019
Despite the drastic impact that Raynaud’s phenomenon can have on an individual’s quality of life, the detrimental effects that the condition may have on mental health are often overlooked.
Thursday 14th February 2019
Arthur has been living with Raynaud’s since childhood, however, he only received his diagnosis last year. This year he decided to take on Mount Kilimanjaro to fundraise and help raise awareness for SRUK.
Tuesday 12th February 2019
Anyone can take part in a clinical trial as long as they meet the eligibility criteria. By supporting trials, you will be helping to find the best treatments possible to manage the symptoms and effects of scleroderma and Raynaud’s.
